Want to join the conversation?
$BA reports quarterly loss on charges. The company reported 2Q16 net loss of $0.37 per share, including a $3.23 per share impact. $BA said its 787 cost reclassification resulted in a charge of $1.33 per share while the 747 program generated a charge of $1.28 per share. The KC-46 Tanker program accounted for a charge of $0.62 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?